Skip to content

cross sectional study for the relationship between adiposity and cathelicidin

cross sectional study for the relationship between adiposity and cathelicidin - cross sectional study for the relationship between adiposity and cathelicidin

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000047680
Enrollment
100
Registered
2022-05-10
Start date
2022-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity group (subcutaneous fat type obesity group, internal organs fat type obesity group, metabolic syndrome group, the metabolic syndrome group which had a coronary disease) and volunteer group of the normal BMI

Interventions

None listed

Sponsors

Wakayama medical university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Obesity group (subcutaneous fat type obesity group, internal organs fat type obesity group, metabolic syndrome group, the metabolic syndrome group which had a coronary disease) and volunteer group of the normal BMI Patients with written informed consent

Exclusion criteria

Exclusion criteria: patients judged as inappropriate by the doctor

Design outcomes

Primary

MeasureTime frame
cathelicidin, and cell free DNA in blood

Countries

Japan

Contacts

Public ContactMotoki Taniguchi

Wakayama medical university department of cardiovascular medicine

motoki@wakayama-med.ac.jp073-447-2300

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026